| HealthPartners | Amyloid monoclonal antibodies | 2026-07-01 |
| HealthPartners | Anifrolumab (Saphnelo®) and belimumab (Benlysta®) | 2026-07-01 |
| HealthPartners | Biologics for allergy and pulmonology | 2026-07-01 |
| HealthPartners | Biologics for chronic inflammatory diseases | 2026-07-01 |
| HealthPartners | Biologics requiring IV induction dosing | 2026-07-01 |
| HealthPartners | Blood factor and non-factor products for hemophilia | 2026-07-01 |
| HealthPartners | Burosumab (Crysvita®) | 2026-07-01 |
| HealthPartners | Burosumab (Crysvita®) – Minnesota Health Care | 2026-07-01 |
| HealthPartners | These services may or may not be covered by your HealthPartners plan. Please see your plan documents for your | 2026-07-01 |
| HealthPartners | Eptinezumab-jjmr (Vyepti™) | 2026-07-01 |